Results 281 to 290 of about 1,676,393 (393)

Thermoplastic Elastomeric Bottlebrush Copolymer Glue Electrolyte Featuring Dual‐Ion Transport Channels and Strong Segregation: Experimental and Simulation Insights

open access: yesAdvanced Functional Materials, EarlyView.
A thermoplastic elastomeric glue electrolyte featuring a strongly segregated PVA‐g‐PTFP bottlebrush copolymer exhibits a nanoscale domain architecture, dual‐ion transport pathways, and universal strong interfacial adhesion. The system delivers high ionic conductivity, wide electrochemical stability, and mechanical robustness, offering a versatile ...
Hyuk Jin Roh   +4 more
wiley   +1 more source

Development of Substrate‐Independent Antifouling and Bactericidal Surfaces Using Visible Light Cross‐Linked Hydrogel Coatings for Biomedical Applications

open access: yesAdvanced Healthcare Materials, EarlyView.
A new antifouling, antithrombogenic, and bactericidal hydrogel coating method is developed for implantable medical devices. The hydrogel coating can be easily formed by visible‐light crosslinking and is universally applicable to all substrates, ranging from polymers to metals.
Soonjong Roh   +4 more
wiley   +1 more source

Graded Hydroxyapatite Triply Periodic Minimal Surface Structures for Bone Tissue Engineering Applications

open access: yesAdvanced Healthcare Materials, EarlyView.
This study investigates the role of triply periodic minimal structures in load bearing bone tissue engineering applications. Research uses a combination of mechanical testing, material characterization, and in vitro tests to study the impact of TPMS lattice structures (gyroid, lidinoid and split‐P).
Tejas M. Koushik   +2 more
wiley   +1 more source

Reservoir‐Type Subcutaneous Implantable Devices Containing Porous Rate Controlling Membranes for Sustained Delivery of Risperidone

open access: yesAdvanced Healthcare Materials, EarlyView.
This study presents a novel implantable drug delivery systemwith a biodegradable poly(caprolactone) membrane and compressed drug core forsustained release. These implantable devices deliver risperidone in vitro for 170 days and in vivo for 49 days in rats, showing promise for chronic conditions like schizophrenia.
Linlin Li   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy